Statements (54)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
Cannabis
|
| gptkbp:aroma |
odorless
|
| gptkbp:boilingPoint |
175–178 °C
|
| gptkbp:canBeSynthesizedFrom |
gptkb:CBD
gptkb:Delta-9_THC |
| gptkbp:CASNumber |
5957-75-5
|
| gptkbp:chemicalFormula |
C21H30O2
|
| gptkbp:color |
colorless to pale amber
|
| gptkbp:discoveredBy |
gptkb:Roger_Adams
|
| gptkbp:discoveredIn |
1941
|
| gptkbp:effect |
relaxation
euphoria altered perception |
| gptkbp:foundIn |
cannabis
|
| https://www.w3.org/2000/01/rdf-schema#label |
Delta-8 THC
|
| gptkbp:isomerOf |
gptkb:Delta-9_THC
|
| gptkbp:IUPACName |
(6aR,10aR)-6,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydrobenzo[c]chromen-1-ol
|
| gptkbp:legalStatus |
varies by jurisdiction
|
| gptkbp:marketedAs |
legal alternative to Delta-9 THC
|
| gptkbp:metabolism |
liver
|
| gptkbp:molecularWeight |
314.464 g/mol
|
| gptkbp:psychoactive |
true
|
| gptkbp:regulates |
not FDA approved
|
| gptkbp:relatedTo |
gptkb:CBD
gptkb:CBN Delta-10 THC |
| gptkbp:routeOfAdministration |
oral
inhalation sublingual |
| gptkbp:sells |
gummies
capsules edibles tinctures vape cartridges distillate |
| gptkbp:sideEffect |
anxiety
paranoia red eyes increased heart rate drowsiness dry mouth impaired coordination |
| gptkbp:solubility |
lipid-soluble
|
| gptkbp:source |
hemp
marijuana |
| gptkbp:status |
Schedule I (US, federal)
|
| gptkbp:subjectOf |
scientific research
public health concern FDA warnings state bans |
| gptkbp:usedFor |
recreational purposes
potential medical uses |
| gptkbp:bfsParent |
gptkb:Hometown_Hero
|
| gptkbp:bfsLayer |
7
|